Alzheimer's drug 'rip-off'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Famlies of Alzheimer's patients desperate to get the first licensed drug to treat the disease are being charged up to pounds 200 a month - three times the NHS price - by pharmacists who have been accused by doctors of unacceptable profiteering.
Donepezil is licensed in the UK but is not widely available on the NHS, leading to some patients taking out private prescriptions.
The drug, which has been shown to delay the progress of the disease, costs the NHS pounds 68 for a month's supply. But a team at the Research Institute for the Care of the Elderly, in Bath, which carried out a survey of 62 chemist shops, found that patients were being charged anything from pounds 68.32 to pounds 168.78. A second team of psychiatrists say many people in Surrey are having to pay pounds 200 a month.
"Doctors prescribing Donepezil in good faith will be astonished at the mark-up being charged by some pharmacists," says the Bath team in a letter to the British Medical Journal.
A spokesman for the Pharmaceutical Society said: "Pharmacists are professional people and are at liberty to charge the fee that they see fit."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments